Quadrant HealthCom is targeting nurse practitioners and physician assistants with its launch of Convenient Care, the official journal of the Convenient Care Association.

The decision by Sepracor to in-license the US marketing rights to inhaled corticosteroid Alvesco caps a four-year commercial and regulatory odyssey for the asthma drug.

Healthcare group purchasing and resource management organization Consorta, announced today that it will launch EverGreen magazine, the first and only healthcare industry magazine focused on green procurement and sustainable environmental practices.

Introduced last week, MM&M's New Drug Dossier is enjoying a successful debut, as pharmaceutical marketers continue to recognize the utility of this business intelligence tool.

MM&M's New Drug Dossier is designed to give pharmaceutical marketers authoritative promotional and clinical insights on the latest new molecular entities in one online resource.

Auriga Laboratories, a specialty pharmaceutical company announced the launch of Coraz Lotion (hydrocortisone lotion USP, 2%) indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses, such as Seborrheic Dermatitis.

GlaxoSmithKline launched its cervical cancer vaccine Cervarix in the UK on Tuesday, pricing it at about the same level as rival treatment, Merck’s Gardasil.

Shire has amassed a 560-person sales force in advance of its Monday launch of new attention deficit hyperactivity drug Vyvanse.

GlaxoSmithKline continues to prepare for the rollout of its new OTC diet pill Alli.

Bradley Pharmaceuticals is hiring about 60 reps as it gears up to launch Elestrin, a low-dose estrogen gel for treating the symptoms of menopause.